<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36655704</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1751-1402</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The European journal of general practice</Title><ISOAbbreviation>Eur J Gen Pract</ISOAbbreviation></Journal><ArticleTitle>Initial symptoms and three months follow-up after acute COVID-19 in outpatients: An international prospective cohort study.</ArticleTitle><Pagination><StartPage>2154074</StartPage><MedlinePgn>2154074</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2154074</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/13814788.2022.2154074</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Most studies on long-term follow-up of patients with COVID-19 focused on hospitalised patients. No prospective study with structured follow-up has been performed in non-hospitalised patients with COVID-19.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To assess long-COVID and post-COVID (WHO definition: symptomatic at least 12&#x2009;weeks), describe lingering symptoms, their impact on daily activities, and general practice visits and explore risk factors for symptom duration in outpatients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A prospective study of adult outpatients with confirmed SARS-CoV-2 infection and symptoms consistent with COVID-19 in 11 European countries, recruited during 2020 and 2021 from primary care and the community. Structured follow-up by phone interviews (symptom rating, symptom impact on daily activities and general practice visits) was performed at weeks 2, 4, 8, and 12 by study personnel. Data was analysed descriptively by using correlation matrixes and Cox regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 270 enrolled patients, 52% developed long-COVID and 32% post-COVID-syndrome. When only considering the presence of moderate or (very) severe symptoms at weeks 8 and 12, these percentages were 28% and 18%, respectively. Fatigue was the most often reported symptom during follow-up. The impact of lingering symptoms was most evident in sports and household activities. About half (53%) had at least one general practice contact during follow-up. Obese patients took twice as long to return to usual health (HR: 0.5, 95%CI: 0.3-0.8); no other risk profile could predict lingering symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Long-COVID and post-COVID are also common in outpatients. In 32%, it takes more than 12&#x2009;weeks to return to usual health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hedin</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1931-2752</Identifier><AffiliationInfo><Affiliation>Futurum, Region J&#xf6;nk&#xf6;ping County, and Department of Health, Medicine and Caring Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences in Malm&#xf6;, Family Medicine, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Velden</LastName><ForeName>Alike W</ForeName><Initials>AW</Initials><Identifier Source="ORCID">0000-0002-9443-2837</Identifier><AffiliationInfo><Affiliation>Julius Center of Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Malene Plejdrup</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0002-8444-1369</Identifier><AffiliationInfo><Affiliation>Center for General Practice at, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moberg</LastName><ForeName>Anna B</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0001-5431-8469</Identifier><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balan</LastName><ForeName>Anca</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5038-1505</Identifier><AffiliationInfo><Affiliation>Balan Medfarm SRL, Cluj Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruno</LastName><ForeName>Pascale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8022-114X</Identifier><AffiliationInfo><Affiliation>D&#xe9;partement de Sant&#xe9; Publique, Universit&#xe9; C&#xf4;te d'Azur, Centre Hospitalier Universitaire de Nice, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coenen</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1238-8052</Identifier><AffiliationInfo><Affiliation>Centre for General Practice, Department of Family Medicine &amp; Population Health, University of Antwerp, Antwerp (Wilrijk), Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansen</LastName><ForeName>Eskild</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for General Practice at, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalczyk</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7524-2085</Identifier><AffiliationInfo><Affiliation>Centre for Family and Community Medicine, the Faculty of Health Sciences, the Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurotschka</LastName><ForeName>Peter Konstantin</ForeName><Initials>PK</Initials><Identifier Source="ORCID">0000-0003-3750-6147</Identifier><AffiliationInfo><Affiliation>Department of General Practice, University Hospital W&#xfc;rzburg, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Linde</LastName><ForeName>Sanne R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Julius Center of Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malania</LastName><ForeName>Lile</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0671-4752</Identifier><AffiliationInfo><Affiliation>National Center for Disease Control and Public Health, Tbilisi, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohde</LastName><ForeName>J&#xf6;rn</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6086-4455</Identifier><AffiliationInfo><Affiliation>Department of General Practice, University Hospital W&#xfc;rzburg, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verbakel</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7166-7211</Identifier><AffiliationInfo><Affiliation>EPI-Centre, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vornhagen</LastName><ForeName>Heike</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7254-9786</Identifier><AffiliationInfo><Affiliation>Data Science Institute, National University of Galway, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vellinga</LastName><ForeName>Akke</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6583-4300</Identifier><AffiliationInfo><Affiliation>School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Gen Pract</MedlineTA><NlmUniqueID>9513566</NlmUniqueID><ISSNLinking>1381-4788</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="Y">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">daily activities</Keyword><Keyword MajorTopicYN="N">lingering symptoms</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">primary care</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36655704</ArticleId><ArticleId IdType="pmc">PMC10249456</ArticleId><ArticleId IdType="doi">10.1080/13814788.2022.2154074</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO: COVID-19 Explorer. World Health Organisation . [cited 2022 November 22] Available from: https://covid19.who.int/explorer.</Citation></Reference><Reference><Citation>World Health Organisation: Clinical management of COVID-19:interim guidance . 2020. World Health Organisation. [cited 2022 November 22] Available from: https://apps.who.int/iris/handle/10665/332196.</Citation></Reference><Reference><Citation>Mehta OP, Bhandari P, Raut A, et al. . Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front Public Health. 2020;8:582932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844320</ArticleId><ArticleId IdType="pubmed">33520910</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker HR, Gulea C, Koteci A, et al. . GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study. BMJ. 2021;375:e065834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715128</ArticleId><ArticleId IdType="pubmed">34965929</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Cheng X, Feng X, et al. . Clinical symptom differences between mild and severe COVID-19 patients in China: a meta-analysis. Front Public Health. 2020;8:561264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841395</ArticleId><ArticleId IdType="pubmed">33520906</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation: A clinical case definition of post COVID-19 condition by a Delphi consensus . World Health Organisation. [updated 2021.  Oct 6; cited 22 Nov 2022] Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. . Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Velden AW, Van de Pol AC, Bongard E, et al. . Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 european countries. BJGP Open. 2022;6(2):BJGPO.2021.0212. BJGPO.2021.0212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9447323</ArticleId><ArticleId IdType="pubmed">34920989</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. . Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandia R, Singhal S, Alqahtani T, et al. . Emergence of SARS-CoV-2 omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res. 2022;209:112816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8798788</ArticleId><ArticleId IdType="pubmed">35093310</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah F, Myers J, Basu D, et al. . Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, South Africa. Int J Infect Dis. 2022;116:38&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8713416</ArticleId><ArticleId IdType="pubmed">34971823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi PGY, Zayyad H, Wertheim O, et al. . Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. npj Vaccines. 2022;7(1):101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk C. Covid-19: how Europe is approaching long covid. BMJ. 2022;376:o158.</Citation><ArticleIdList><ArticleId IdType="pubmed">35058230</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>